Skin pigmentation and its control: From ultraviolet radiation to stem cells.


Journal

Experimental dermatology
ISSN: 1600-0625
Titre abrégé: Exp Dermatol
Pays: Denmark
ID NLM: 9301549

Informations de publication

Date de publication:
04 2021
Historique:
pubmed: 16 12 2020
medline: 24 3 2022
entrez: 15 12 2020
Statut: ppublish

Résumé

In the light of substantial discoveries in epithelial and hair pigmentation pathophysiology, this review summarizes the current understanding of skin pigmentation mechanisms. Melanocytes are pigment-producing cells, and their key regulating transcription factor is the melanocyte-specific microphthalmia-associated transcription factor (m-MITF). Ultraviolet (UV) radiation is a unique modulator of skin pigmentation influencing tanning pathways. The delayed tanning pathway occurs as UVB produces keratinocyte DNA damage, causing p53-mediated expression of the pro-opiomelanocortin (POMC) gene that is processed to release α-melanocyte-stimulating hormone (α-MSH). α-MSH stimulates the melanocortin 1 receptor (MC1R) on melanocytes, leading to m-MITF expression and melanogenesis. POMC cleavage also releases β-endorphin, which creates a neuroendocrine pathway that promotes UV-seeking behaviours. Mutations along the tanning pathway can affect pigmentation and increase the risk of skin malignancies. MC1R variants have received considerable attention, yet the allele is highly polymorphic with varied phenotypes. Vitiligo presents with depigmented skin lesions due to autoimmune destruction of melanocytes. UVB phototherapy stimulates melanocyte stem cells in the hair bulge to undergo differentiation and upwards migration resulting in perifollicular repigmentation of vitiliginous lesions, which is under sophisticated signalling control. Melanocyte stem cells, normally quiescent, undergo cyclic activation/differentiation and downward migration with the hair cycle, providing pigment to hair follicles. Physiological hair greying results from progressive loss of melanocyte stem cells and can be accelerated by acute stress-induced, sympathetic driven hyperproliferation of the melanocyte stem cells. Ultimately, by reviewing the pathways governing epithelial and follicular pigmentation, numerous areas of future research and potential points of intervention are highlighted.

Identifiants

pubmed: 33320376
doi: 10.1111/exd.14260
pmc: PMC8218595
mid: NIHMS1713835
doi:

Substances chimiques

MITF protein, human 0
Microphthalmia-Associated Transcription Factor 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

560-571

Subventions

Organisme : NIAMS NIH HHS
ID : R01 AR072304
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA163222
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA222871
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR043369
Pays : United States

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

JAMA Dermatol. 2018 Jul 1;154(7):789-795
pubmed: 29898205
JAMA Dermatol. 2015 Jan;151(1):42-50
pubmed: 25230094
Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):E8035-E8044
pubmed: 28878021
Mol Cell Biol. 1998 Dec;18(12):6930-8
pubmed: 9819381
Prev Med. 2015 Dec;81:184-8
pubmed: 26361753
Mol Cell. 2014 Jun 19;54(6):999-1011
pubmed: 24950377
Nature. 2006 Sep 21;443(7109):340-4
pubmed: 16988713
J Invest Dermatol. 2013 Dec;133(12):2753-2762
pubmed: 23702581
Photodermatol Photoimmunol Photomed. 2019 Nov;35(6):387-392
pubmed: 31206816
J Am Acad Dermatol. 2006 Apr;54(4):709-11
pubmed: 16546596
Arch Dermatol Res. 2011 Nov;303(9):623-4
pubmed: 21830160
Annu Rev Genet. 2004;38:365-411
pubmed: 15568981
J Am Acad Dermatol. 2011 Sep;65(3):473-491
pubmed: 21839315
J Am Acad Dermatol. 2014 Dec;71(6):1110-6
pubmed: 25242557
J Invest Dermatol. 2005 Jun;124(6):1326-32
pubmed: 15955111
Pigment Cell Melanoma Res. 2010 Feb;23(1):27-40
pubmed: 19995375
Skin Res Technol. 2007 May;13(2):154-61
pubmed: 17374056
Cell Stem Cell. 2010 Feb 5;6(2):130-40
pubmed: 20144786
J Dermatol Sci. 2011 Jul;63(1):47-54
pubmed: 21536413
Nat Genet. 1994 Sep;8(1):59-65
pubmed: 7987393
Int J Cancer. 2008 Jun 15;122(12):2753-60
pubmed: 18366057
Hum Genet. 2015 Aug;134(8):823-35
pubmed: 25963972
Nat Genet. 2008 Jul;40(7):835-7
pubmed: 18488028
J Invest Dermatol. 2004 May;122(5):1251-5
pubmed: 15140229
Cell Rep. 2017 Jun 13;19(11):2177-2184
pubmed: 28614705
J Pharmacol Exp Ther. 1991 Jul 1;258(1):237-42
pubmed: 1677039
Ann Epidemiol. 2008 Aug;18(8):614-27
pubmed: 18652979
Pigment Cell Melanoma Res. 2013 Mar;26(2):247-58
pubmed: 23279852
Science. 2005 Feb 4;307(5710):720-4
pubmed: 15618488
Int J Cancer. 2015 Jun 1;136(11):2659-67
pubmed: 25382380
J Invest Dermatol. 2018 Jul;138(7):1511-1517
pubmed: 29481903
Int J Cancer. 2013 Jan 1;132(1):42-54
pubmed: 22628150
Arch Dermatol. 2010 Apr;146(4):412-7
pubmed: 20404230
Arch Dermatol. 1966 Feb;93(2):235-6
pubmed: 5904034
Nature. 2020 Jan;577(7792):676-681
pubmed: 31969699
Immunol Rev. 2016 Jan;269(1):11-25
pubmed: 26683142
J Invest Dermatol. 1991 Sep;97(3):410-6
pubmed: 1714927
J Cell Biol. 2006 May 8;173(3):333-9
pubmed: 16651378
FASEB J. 2009 Nov;23(11):3790-807
pubmed: 19641144
J Invest Dermatol. 2008 Nov;128(11):2686-2695
pubmed: 18463680
Cell. 1993 Jul 30;74(2):395-404
pubmed: 8343963
N Engl J Med. 2016 Jul 21;375(3):240-6
pubmed: 27468060
Cochrane Database Syst Rev. 2015 Feb 24;(2):CD003263
pubmed: 25710794
Am J Pathol. 2004 Sep;165(3):741-51
pubmed: 15331399
J Invest Dermatol. 1998 Dec;111(6):941-7
pubmed: 9856800
Nat Genet. 2008 Aug;40(8):963-70
pubmed: 18641651
Arch Dermatol. 1982 Nov;118(11):876-7
pubmed: 7138040
Nature. 2002 Apr 25;416(6883):854-60
pubmed: 11976685
J Invest Dermatol. 1995 Sep;105(3):361-6
pubmed: 7665913
Genes Chromosomes Cancer. 2012 Jul;51(7):654-61
pubmed: 22447455
Acc Chem Res. 2010 Nov 16;43(11):1452-60
pubmed: 20734991
Lancet Child Adolesc Health. 2019 May;3(5):332-342
pubmed: 30872112
J Invest Dermatol. 1970 Oct;55(4):265-8
pubmed: 5471889
Cell. 2014 Jun 19;157(7):1527-34
pubmed: 24949966
Photochem Photobiol. 2008 May-Jun;84(3):679-82
pubmed: 18422874
J Immunol. 2019 Jul 1;203(1):11-19
pubmed: 31209143
Clin Exp Dermatol. 2011 Jan;36(1):33-8
pubmed: 20545951
Nature. 1961 Jan 21;189:176-9
pubmed: 13761067
Nature. 2012 Nov 15;491(7424):449-53
pubmed: 23123854
Br J Dermatol. 2013 Jan;168(1):162-71
pubmed: 23136900
Cell. 1993 Mar 26;72(6):827-34
pubmed: 8458079
J Invest Dermatol. 1979 Aug;73(2):141-3
pubmed: 88488
Pigment Cell Melanoma Res. 2008 Aug;21(4):487-91
pubmed: 18627527
Nat Genet. 2008 Jul;40(7):886-91
pubmed: 18488027
Pigment Cell Res. 1997 Feb-Apr;10(1-2):12-24
pubmed: 9170158
Pigment Cell Melanoma Res. 2010 Dec;23(6):809-19
pubmed: 20819186
Curr Opin Immunol. 2016 Dec;43:81-88
pubmed: 27764715
FASEB J. 2008 Apr;22(4):1155-68
pubmed: 18039926
Cancer Cell. 2004 Dec;6(6):565-76
pubmed: 15607961
Cancer Causes Control. 2011 Mar;22(3):495-501
pubmed: 21221757
Am J Pathol. 2003 Jul;163(1):333-43
pubmed: 12819038
Photochem Photobiol. 2005 Jan-Feb;81(1):135-44
pubmed: 15504086
Nature. 1976 Sep 16;263(5574):239-40
pubmed: 958477
J Invest Dermatol. 1998 Oct;111(4):678-82
pubmed: 9764853
Arch Dermatol. 2006 Jul;142(7):871-6
pubmed: 16847203
Nat Commun. 2016 Jul 12;7:12064
pubmed: 27403562
Photochem Photobiol Sci. 2013 Jan;12(1):54-64
pubmed: 23111621
J Invest Dermatol. 1957 Jan;28(1):33-45
pubmed: 13416674
Genes Dev. 2010 Oct 15;24(20):2276-81
pubmed: 20952536
Arch Biochem Biophys. 2014 Dec 1;563:4-12
pubmed: 25017567
J Invest Dermatol. 1993 Jul;101(1 Suppl):16S-26S
pubmed: 8326150
Nat Genet. 1995 Nov;11(3):328-30
pubmed: 7581459
J Invest Dermatol. 2011 Jun;131(6):1226-33
pubmed: 21326292
Cell. 2007 Mar 9;128(5):853-64
pubmed: 17350573
Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1853-1856
pubmed: 31488411
Cell. 2011 Jun 10;145(6):941-955
pubmed: 21663796
J Clin Endocrinol Metab. 2004 Jun;89(6):2557-62
pubmed: 15181023
Hum Genet. 2019 Jun;138(6):635-647
pubmed: 30980179
JAMA Dermatol. 2013 Jan;149(1):68-73
pubmed: 23407924
Nat Med. 2013 Jul;19(7):924-9
pubmed: 23749232
Mol Cell. 2013 Aug 22;51(4):409-22
pubmed: 23973372
Pigment Cell Melanoma Res. 2011 Feb;24(1):136-47
pubmed: 20979596
Exp Dermatol. 2019 Jun;28(6):647-655
pubmed: 29704874
Nat Genet. 1998 Jun;19(2):155-7
pubmed: 9620771
Genes Dev. 2019 Aug 1;33(15-16):983-1007
pubmed: 31123060
Photochem Photobiol. 2010 Jul-Aug;86(4):757-64
pubmed: 20408987
Eur J Cancer. 2010 May;46(8):1413-20
pubmed: 20189796
FASEB J. 2001 Mar;15(3):645-58
pubmed: 11259383
Cell Rep. 2016 May 10;15(6):1291-302
pubmed: 27134165
Cell. 2002 Jun 14;109(6):707-18
pubmed: 12086670
Pigment Cell Res. 2003 Jun;16(3):208-14
pubmed: 12753387
J Invest Dermatol. 1970 Jul;55(1):65-70
pubmed: 5425068
Nat Commun. 2019 Jan 21;10(1):358
pubmed: 30664655
Arch Dermatol. 2005 Aug;141(8):963-6
pubmed: 16103324
J Mol Endocrinol. 2016 May;56(4):T27-37
pubmed: 26643913

Auteurs

Joseph Michael Yardman-Frank (JM)

The University of New Mexico School of Medicine, Albuquerque, NM, USA.

David E Fisher (DE)

Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH